QURE
uniQure N.V.
NASDAQ · Healthcare · Biotechnology · NL
$44.50
−0.80%Margins
Gross margin
22.8%
EBITDA margin
-969.7%
EBIT margin
-1089.1%
Net margin
-1350.7%
FCF margin
-862.3%
-77.8%
Return on equity
-25.6%
Return on assets
-52.6%
Return on invested capital
0.02x
Asset turnover
-$160.8M
Cash from operations
$12
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026